These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1624798)

  • 1. Transforming growth factor-beta 1 inhibits murine immediate and delayed type hypersensitivity.
    Meade R; Askenase PW; Geba GP; Neddermann K; Jacoby RO; Pasternak RD
    J Immunol; 1992 Jul; 149(2):521-8. PubMed ID: 1624798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiation of delayed-type hypersensitivity by low doses of monoclonal IgE antibody. Mediation by serotonin and inhibition by histamine.
    Ptak W; Geba GP; Askenase PW
    J Immunol; 1991 Jun; 146(11):3929-36. PubMed ID: 2033262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective elicitation of delayed-type hypersensitivity in W/Wv and SI/SId mast cell-deficient mice.
    Askenase PW; Van Loveren H; Kraeuter-Kops S; Ron Y; Meade R; Theoharides TC; Nordlund JJ; Scovern H; Gerhson MD; Ptak W
    J Immunol; 1983 Dec; 131(6):2687-94. PubMed ID: 6605986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for mast cells and the vasoactive amine serotonin in T cell-dependent immunity to tumors.
    Van Loveren H; Den Otter W; Meade R; Terheggen PM; Askenase PW
    J Immunol; 1985 Feb; 134(2):1292-9. PubMed ID: 3871209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different mechanisms of release of vasoactive amines by mast cells occur in T cell-dependent compared to IgE-dependent cutaneous hypersensitivity responses.
    Van Loveren H; Kraeuter-Kops S; Askenase PW
    Eur J Immunol; 1984 Jan; 14(1):40-7. PubMed ID: 6198182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed-type hypersensitivity is mediated by a sequence of two different T cell activities.
    Van Loveren H; Askenase PW
    J Immunol; 1984 Nov; 133(5):2397-401. PubMed ID: 6332849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed-type hypersensitivity initiation by early-acting cells that are antigen mismatched or MHC incompatible with late-acting, delayed-type hypersensitivity effector T cells.
    Ptak W; Herzog WR; Askenase PW
    J Immunol; 1991 Jan; 146(2):469-75. PubMed ID: 1987274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta1 inhibits late-stage mast cell maturation.
    Kashyap M; Bailey DP; Gomez G; Rivera J; Huff TF; Ryan JJ
    Exp Hematol; 2005 Nov; 33(11):1281-91. PubMed ID: 16263412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antigen-binding T cell factor PCl-F sensitizes mast cells for in vitro release of serotonin. Comparison with monoclonal IgE antibody.
    Meade R; Van Lovern H; Parmentier H; Iverson GM; Askenase PW
    J Immunol; 1988 Oct; 141(8):2704-13. PubMed ID: 2459224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
    Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
    J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand.
    Kosiewicz MM; Alard P; Liang S; Clark SL
    Int Immunol; 2004 May; 16(5):697-706. PubMed ID: 15096489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta 1 selectively inhibits IL-3-dependent mast cell proliferation without affecting mast cell function or differentiation.
    Broide DH; Wasserman SI; Alvaro-Gracia J; Zvaifler NJ; Firestein GS
    J Immunol; 1989 Sep; 143(5):1591-7. PubMed ID: 2527268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta prevents stem cell factor-mediated rescue of mast cells from apoptosis after IL-3 deprivation.
    Mekori YA; Metcalfe DD
    J Immunol; 1994 Sep; 153(5):2194-203. PubMed ID: 7519644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cell activation and vascular alterations in immediate hypersensitivity-like reactions induced by a T cell-derived antigen-binding factor.
    Kops SK; Van Loveren H; Rosenstein RW; Ptak W; Askenase PW
    Lab Invest; 1984 Apr; 50(4):421-34. PubMed ID: 6608629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific aqueous humor factors induce activation of regulatory T cells.
    Nishida T; Taylor AW
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2268-74. PubMed ID: 10476792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel role for TGF-beta and IL-10 in the induction of immune privilege.
    D'Orazio TJ; Niederkorn JY
    J Immunol; 1998 Mar; 160(5):2089-98. PubMed ID: 9498745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of delayed-type hypersensitivity-like responses in the mouse lung, determined with histological procedures: serotonin, T-cell suppressor-inducer factor and high antigen dose tolerance regulate the magnitude of T-cell dependent inflammatory reactions.
    Garssen J; Nijkamp FP; Wagenaar SS; Zwart A; Askenase PW; Van Loveren H
    Immunology; 1989 Sep; 68(1):51-8. PubMed ID: 2807371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of mouse peritoneal mast cell secretory function by stem cell factor, IL-3 or IL-4.
    Coleman JW; Holliday MR; Kimber I; Zsebo KM; Galli SJ
    J Immunol; 1993 Jan; 150(2):556-62. PubMed ID: 7678275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 125I-fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin. Demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells.
    Wershil BK; Mekori YA; Murakami T; Galli SJ
    J Immunol; 1987 Oct; 139(8):2605-14. PubMed ID: 3655368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [125I]fibrin deposition occurs at both early and late intervals of IgE-dependent or contact sensitivity reactions elicited in mouse skin. Mast cell-dependent augmentation of fibrin deposition at early intervals in combined IgE-dependent and contact sensitivity reactions.
    Mekori YA; Galli SJ
    J Immunol; 1990 Dec; 145(11):3719-27. PubMed ID: 2246510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.